Is IBIO a buy? - Seeking Alpha

Quote & Headlines Market Currents StockTalk

Today 5d 1m 3m 1y 5y 10y

52wk high:

52wk low:

EPS:

PE:

Div Rate:

Yield:

Market Cap:

Volume:

501 people get IBIO articles and Market Currents by email alert.

Get email alerts on IBIO »

HEADLINES:

iBio, Inc. closes $4.2 million public offering and terminates At-the-market offering

PR Newswire (Apr 29, 2013)
iBio, Inc. Prices $4.2 Million Public Offering

PR Newswire (Apr 23, 2013)
iBio, Inc. Announces Proposed Public Offering

PR Newswire (Apr 22, 2013)
iBio Passes Commercial Technology Transfer Milestone

PR Newswire (Apr 22, 2013)
iBio, Inc. receives Notice from NYSE MKT Staff that Company currently is not in compliance with an additional Continued Listing Standard

PR Newswire (Apr 22, 2013)
GE Healthcare: Driving Growth Through Alliances And Acquisitions
Emerging Equities • Fri, Apr 12 • 6 Comments
GE alliance awarded contract to design new plant-based manufacturing facility in Brazil

PR Newswire (Apr 9, 2013)
Flu Stocks For Investors To Consider
Stock Investor • Mon, Apr 8 • 6 Comments
iBio Selects Proprietary Recombinant C1 Inhibitor for Clinical Development

PR Newswire (Mar 26, 2013)
iBio Adds to iBioModulator Portfolio and Product Pipeline

PR Newswire (Mar 13, 2013)
iBio Adds New Therapeutic Antibody to Its Pipeline

PR Newswire (Mar 4, 2013)
iBio, Inc. Receives Anticipated Notice from NYSE MKT that Company is Below Certain Continued Listing Standards

PR Newswire (Mar 4, 2013)
iBio And Caliber Biotherapeutics Establish License And Collaboration Relationship

PR Newswire (Feb 19, 2013)
iBio, Inc. Receives Approval from NYSE MKT of Compliance Plan

PR Newswire (Feb 13, 2013)
iBio Announces At-the-Market Equity Offering

PR Newswire (Feb 1, 2013)
Change In Global Weather Patterns, Australia Heat Wave, Flu Virus
James Roemer • Mon, Jan 14 • 5 Comments
Speculative Flu Vaccine Stocks To Consider: Novavax, iBio, BioCryst, And Inovio
BuySellShort • Fri, Jan 11 • 14 Comments
iBio Announces New Appointment to Board of Directors and New Addition to Executive Management Team

PR Newswire (Dec 21, 2012)
National Institute of Health Awards Contract to Support Use of iBio's Proprietary Technology for Improved Anthrax Vaccine

PR Newswire (Dec 5, 2012)
Why Cash Overrules The Momentary Market Bounce
James Stocklasar Thomas Jr. • Tue, Nov 27, 2012 • 14 Comments

To learn more about Seeking Alpha Pro, click here.

Why Buying iBio Makes Good Sense
James Stocklasar Thomas Jr. • Thu, Jul 26, 2012 • 12 Comments
Tuesday's Top Biotech Chart: iBio Inc.
James Stocklasar Thomas Jr. • Tue, Jul 24, 2012 • 41 Comments
Plant-Made Pharmaceuticals And The Democratization Of Health Care
Julian Cruz • Fri, Apr 27, 2012 • 26 Comments
iBio Incorporated: Speculative Long-Term Investment With Short-Term Catalyst
Scott Matusow • Mon, Apr 9, 2012 • 23 Comments
IBIO: Pharma Stock With Much Downside Risk And Low Upside Potential
Adam Gefvert • Wed, Nov 2, 2011 • 14 Comments
Finding the Underlying Value in iBio, Inc.
Sam Huebner • Thu, Aug 4, 2011 • 8 Comments
iBio: Recent Lull Offers Opportunity to the Patient Investor
Steven Breazzano • Wed, Jul 27, 2011 • 9 Comments
iBio Still Overvalued; More Dilution Likely
Ian Bezek • Wed, Jun 29, 2011 • 21 Comments
What Investors Should Know About iBio's Share-Based Compensation
Joseph Nicolay • Wed, Mar 2, 2011 • 12 Comments
iBio: Risky, But Early Stage Pipeline Potentially Offers Long-Term Reward
Steven Breazzano • Fri, Feb 11, 2011 • 17 Comments
iBio: A True Paradigm Shift
Ian Cassel • Mon, Jan 24, 2011 • 6 Comments
IBio Headed for $10 Level?
M. E. Garza • Thu, Jan 13, 2011 • 6 Comments

GE Healthcare: Driving Growth Through Alliances And Acquisitions
Emerging Equities • Fri, Apr 12 • 6 Comments
Flu Stocks For Investors To Consider
Stock Investor • Mon, Apr 8 • 6 Comments
Change In Global Weather Patterns, Australia Heat Wave, Flu Virus
James Roemer • Mon, Jan 14 • 5 Comments
Speculative Flu Vaccine Stocks To Consider: Novavax, iBio, BioCryst, And Inovio
BuySellShort • Fri, Jan 11 • 14 Comments
Why Cash Overrules The Momentary Market Bounce
James Stocklasar Thomas Jr. • Tue, Nov 27, 2012 • 14 Comments
$33,000 Portfolio: Mostly Cash Ahead Of Elections And Snow-Hurricanes
Joe Springer • Tue, Oct 30, 2012 • 23 Comments
Under Construction Rehash: Buy Acadia And Astex
James Stocklasar Thomas Jr. • Thu, Sep 20, 2012 • 24 Comments
3 Vaccine Companies With Upcoming Catalysts - Part II
Markus Aarnio • Wed, Sep 12, 2012 • 2 Comments
1 Rallying Bio/Pharma To Sell, 5 That Look To Keep Rallying
Joe Springer • Wed, Aug 8, 2012 • 7 Comments
As Hoped, Biotech And Drugs March To Their Own Beat
Joe Springer • Tue, Aug 7, 2012 • 1 Comment
Why Zalicus Looks Ready For A Bullish Move
James Stocklasar Thomas Jr. • Tue, Aug 7, 2012 • 20 Comments
Bear Raids And Tree Shaking In Biotechnology And Drugs
Joe Springer • Tue, Aug 7, 2012 • 13 Comments
Rituxan And Its Biosimilar Competitors
Peter Geschek • Mon, Jul 30, 2012 • 7 Comments
$33,000 American Portfolio: Closing A Position And Moving Into Bio And Pharma
Joe Springer • Mon, Jul 23, 2012 • 14 Comments
Why Early Tuesday's Biotech Edge Is Bullish
James Stocklasar Thomas Jr. • Tue, Jul 17, 2012 • 17 Comments
Get In Early Monday On These Biotech Favorites
James Stocklasar Thomas Jr. • Mon, Jul 16, 2012 • 30 Comments
4 Stocks In The Biotech Doghouse
James Stocklasar Thomas Jr. • Wed, May 30, 2012 • 13 Comments
Hitting The Jackpot With Small Cap Bio Pharma Investment, Part 1
Scott Matusow • Fri, May 11, 2012 • 60 Comments
Wednesday's Bio Pharma Drug Approval And Catalyst Watch List
Scott Matusow • Wed, May 2, 2012 • 15 Comments
Biotechs On The Move For Today
Scott Matusow • Wed, Apr 25, 2012 • 30 Comments

There are no Transcripts on IBIO.

iBio, Inc. closes $4.2 million public offering and terminates At-the-market offering

PR Newswire (Apr 29, 2013)
iBio, Inc. Prices $4.2 Million Public Offering

PR Newswire (Apr 23, 2013)
iBio, Inc. Announces Proposed Public Offering

PR Newswire (Apr 22, 2013)
iBio Passes Commercial Technology Transfer Milestone

PR Newswire (Apr 22, 2013)
iBio, Inc. receives Notice from NYSE MKT Staff that Company currently is not in compliance with an additional Continued Listing Standard

PR Newswire (Apr 22, 2013)
GE alliance awarded contract to design new plant-based manufacturing facility in Brazil

PR Newswire (Apr 9, 2013)
iBio Selects Proprietary Recombinant C1 Inhibitor for Clinical Development

PR Newswire (Mar 26, 2013)
iBio Adds to iBioModulator Portfolio and Product Pipeline

PR Newswire (Mar 13, 2013)
iBio Adds New Therapeutic Antibody to Its Pipeline

PR Newswire (Mar 4, 2013)
iBio, Inc. Receives Anticipated Notice from NYSE MKT that Company is Below Certain Continued Listing Standards

PR Newswire (Mar 4, 2013)
iBio And Caliber Biotherapeutics Establish License And Collaboration Relationship

PR Newswire (Feb 19, 2013)
iBio, Inc. Receives Approval from NYSE MKT of Compliance Plan

PR Newswire (Feb 13, 2013)
iBio Announces At-the-Market Equity Offering

PR Newswire (Feb 1, 2013)
iBio Announces New Appointment to Board of Directors and New Addition to Executive Management Team

PR Newswire (Dec 21, 2012)
National Institute of Health Awards Contract to Support Use of iBio's Proprietary Technology for Improved Anthrax Vaccine

PR Newswire (Dec 5, 2012)
iBio, Inc. Receives Notice from NYSE MKT Staff that Company Currently is Below Certain Continued Listing Standards

PR Newswire (Nov 23, 2012)
New Patent Allowance Expands iBio's iBioModulator™ IP Portfolio

PR Newswire (Oct 22, 2012)
New Patent Expands iBio's Bio-Defense IP Portfolio

PR Newswire (Oct 3, 2012)
iBio to Present at the 14th Annual Rodman & Renshaw Conference

PR Newswire (Sep 6, 2012)
iBio, Inc. and GE Healthcare form new global alliance

PR Newswire (Jul 26, 2012)

IBIO vs. ETF Alternatives

Company Description

Currently, there's no company description for IBIO.

Sector: Healthcare

Industry: Biotechnology

Country: United States

sheldond
$IBIO some people bought but the opportunity will soon pass. Tooooooo easy and no more ATM equals good news and a bottom! Buy IBIO!
May 2, 7:37 PM
Reply (12)

• !Report Abuse
View all 12 replies
Gtg007: But might buy more shares on MNKD on next low and start LONG position on INO....
May 11, 8:48 AM
• !Report Abuse
Gtg007: Let me know if u think about any negative of going LONG on INO and if u see any chance of MNKD going around 4 again, so that i can buy:)
May 11, 8:51 AM
• !Report Abuse
Add a reply...

140 characters

sheldond
$IBIO after dilution does IBIO have the money to make it to a catalyst? I think so order filled earlier. Worth a flyer before anyone else.
Apr 23, 11:04 AM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Joe Springer
Here's the latest $33,000 article, we stand at $35,814.50 http://seekingalpha.com/a/kltb $PSTI $SPPI $ARNA $ACI $MNKD $IBIO $ATRS #Sandy
10/30/12
Reply (3)

• !Report Abuse
View all 3 replies
Joe Springer: Hi IV, May 25 was start, I try to limit the trades so that it is replicable, 2 month average per trade about: http://seekingalpha.com/p/e7pf
10/30/12
• !Report Abuse
sundate36: Is anyone buying ARNA at 8.00 today?
10/31/12
• !Report Abuse
Add a reply...

140 characters

Joe Springer
$33,000 Portfolio -- Selling biotech to put proceeds in $MNKD, love the price and they are funded now, more to come $PSTI $IBIO $ATRS $ACI
10/18/12
Reply (5)

• !Report Abuse
View all 5 replies
joe kelly: As a percentage of portfolio, how large is the MNKD investment Joe?
10/19/12
• !Report Abuse
Joe Springer: That would put it in the 20% range roughly, I have to do the math Joe
10/19/12
• !Report Abuse
Add a reply...

140 characters

iadops40
Huge all-star biotech conference (Rodman & Renshaw) in New York Sept. 9-11 CLSN GALE GERN IBIO INO KERX NVAX NBS ONTY VVUS
8/28/12
Reply (2)

• !Report Abuse
View all 2 replies
iadops40: http://bit.ly/RntWCr
8/28/12
• !Report Abuse
DAG1996: thanks for sharing that.
8/28/12
• !Report Abuse
Add a reply...

140 characters

iadops40
Huge all-star biotech conference (Rodman & Renshaw) in New York Sept. 9-11 CLSN GALE GERN IBIO INO KERX NVAX NBS ONTY VVUS
8/27/12
Reply (1)

• !Report Abuse
View all 1 replies
iadops40: http://bit.ly/RntWCr
8/27/12
• !Report Abuse
Add a reply...

140 characters

Joe Springer
$VVUS $SPPI $OMPI $ARIA $PSTI $NEPT $IBIO $CRTX $AMGN Got one warning about Bios coming, some that rallied: http://seekingalpha.com/a/gxpr
8/8/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Joe Springer
$IBIO $PSTI Drugs are quick: http://seekingalpha.com/a/gu2x
8/7/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

LEIGHDIST
would you believe that IBIO ticker symbol flashed on squawk box this morning, i had never seen that before
7/26/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

James Stocklasar Thomas Jr.
check out IBIO ... got major news today...
7/26/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

LATEST REPLIES

sheldond
$IBIO some people bought but the opportunity will soon pass. Tooooooo easy and no more ATM equals good news and a bottom! Buy IBIO!
May 2, 7:37 PM
Reply (12)

• !Report Abuse
View all 12 replies
Gtg007: But might buy more shares on MNKD on next low and start LONG position on INO....
May 11, 8:48 AM
• !Report Abuse
Gtg007: Let me know if u think about any negative of going LONG on INO and if u see any chance of MNKD going around 4 again, so that i can buy:)
May 11, 8:51 AM
• !Report Abuse
Add a reply...

140 characters

Joe Springer
Here's the latest $33,000 article, we stand at $35,814.50 http://seekingalpha.com/a/kltb $PSTI $SPPI $ARNA $ACI $MNKD $IBIO $ATRS #Sandy
10/30/12
Reply (3)

• !Report Abuse
View all 3 replies
Joe Springer: Hi IV, May 25 was start, I try to limit the trades so that it is replicable, 2 month average per trade about: http://seekingalpha.com/p/e7pf
10/30/12
• !Report Abuse
sundate36: Is anyone buying ARNA at 8.00 today?
10/31/12
• !Report Abuse
Add a reply...

140 characters

Joe Springer
$33,000 Portfolio -- Selling biotech to put proceeds in $MNKD, love the price and they are funded now, more to come $PSTI $IBIO $ATRS $ACI
10/18/12
Reply (5)

• !Report Abuse
View all 5 replies
joe kelly: As a percentage of portfolio, how large is the MNKD investment Joe?
10/19/12
• !Report Abuse
Joe Springer: That would put it in the 20% range roughly, I have to do the math Joe
10/19/12
• !Report Abuse
Add a reply...

140 characters

iadops40
Huge all-star biotech conference (Rodman & Renshaw) in New York Sept. 9-11 CLSN GALE GERN IBIO INO KERX NVAX NBS ONTY VVUS
8/28/12
Reply (2)

• !Report Abuse
View all 2 replies
iadops40: http://bit.ly/RntWCr
8/28/12
• !Report Abuse
DAG1996: thanks for sharing that.
8/28/12
• !Report Abuse
Add a reply...

140 characters

iadops40
Huge all-star biotech conference (Rodman & Renshaw) in New York Sept. 9-11 CLSN GALE GERN IBIO INO KERX NVAX NBS ONTY VVUS
8/27/12
Reply (1)

• !Report Abuse
View all 1 replies
iadops40: http://bit.ly/RntWCr
8/27/12
• !Report Abuse
Add a reply...

140 characters

James Stocklasar Thomas Jr.
IBIO and GE Healthcare form new global alliance http://yhoo.it/MnELQL IBIO is about to make a LOT OF MONEY!!!
7/26/12
Reply (5)

• !Report Abuse
View all 5 replies
James Stocklasar Thomas Jr.: IBIO is running hot going into the open. Should be a fun day!!! I also think there's going to be more days to follow, so plenty of upside
7/26/12
• !Report Abuse
James Stocklasar Thomas Jr.: IBIO under 'short' attack as price moves higher on news. Go to their website and read IBIO news -- major deal with GE Healthcare
7/26/12
• !Report Abuse
Add a reply...

140 characters

Michael Bryant
Wonder if iBio (IBIO) is going back up to $4. http://yhoo.it/IyqW1d;c=
5/2/12
Reply (3)

• !Report Abuse
View all 3 replies
chuckholladay: Put some money on it and find out.
5/2/12
• !Report Abuse
iadops40: bullish on IBIO, NVAX, AMRN, PPHM...long
5/2/12
• !Report Abuse
Add a reply...

140 characters

Scott Matusow
$IBIO up $0.18, 12%, $PLX up $0.55 7.91% in after hour trading.
5/1/12
Reply (11)

• !Report Abuse
View all 11 replies
iadops40: Thanks Scott, I know you are a busy guy. I am also curious if you have any insight or plans to cover PPHM, good pipeline
5/2/12
• !Report Abuse
mofisher22: Scott, good news ibio, thanks for your pr, looks like dvax, hep drug, is great buy out potential. Let me know how dd is going on NVIV
5/2/12
• !Report Abuse
Add a reply...

140 characters

iadops40
IBIO up 29% in after hours trade riding PLX's FDA approval http://bloom.bg/KFVaSh
5/1/12
Reply (1)

• !Report Abuse
View all 1 replies
iadops40: yeah, but for those who bought on the dip will make off like bandits. Could rally up to $2.00 in the short term.
5/1/12
• !Report Abuse
Add a reply...

140 characters

Scott Matusow
$PLX's Taliglucerase approved. stock rallying, also rallying is $IBIO
5/1/12
Reply (6)

• !Report Abuse
View all 6 replies
0123456789: YES!
5/1/12
• !Report Abuse
0123456789: YES!
5/1/12
• !Report Abuse
Add a reply...

140 characters

iadops40
Biotech's are up big today...finally back in the green...AMRN, PPHM, KERX, PPHM, IBIO
4/20/12
Reply (11)

• !Report Abuse
View all 11 replies
FortSumter: So you're holding IBIO until 5/1? Didn't understand your comment related to it and PLX. I sold out of VVUS for 110%. Made me too nervous.
4/21/12
• !Report Abuse
FortSumter: Bought AFFY prior to approval. Didn't expect the drop after though. Up maybe 10% but will hold until >$12. Also currently under on IDIX.
4/21/12
• !Report Abuse
Add a reply...

140 characters

Scott Matusow
$IBIO and $PATH because both offer the biggest multi bag potential if things work out for them $PSDV as well
4/12/12
Reply (1)

• !Report Abuse
View all 1 replies
Winning Will: Scott, good news out for HZNP .you still holding shares? I bought in at 3.70 sold a small portion at 4.25 before it fell. Thnks 4 this one!
4/12/12
• !Report Abuse
Add a reply...

140 characters

Scott Matusow
My new video explaining what real pump and dump is, small cap investing, and $IBIO rally @ http://bit.ly/HFR0Up
4/10/12
Reply (17)

• !Report Abuse
View all 17 replies
Darren_00: Scott do you think it;s time to sell off $BDSI for short gains or hang on?
4/12/12
• !Report Abuse
Scott Matusow: re fer to my newly released article
4/12/12
• !Report Abuse
Add a reply...

140 characters

Scott Matusow
$IBIO filling gap in bad market. I still hold some shares, didn't have a lot, sold some pre market. cannot expect rally in this market
4/9/12
Reply (4)

• !Report Abuse
View all 4 replies
Pescoe: Hi Scott: Now, what's for tomorrow. Love your picks. Thanks.
4/9/12
• !Report Abuse
Aloha96815: Scott, Arna is up on the news that VVUS PDUFA has been delayed three months. :-)
4/9/12
• !Report Abuse
Add a reply...

140 characters

Scott Matusow
$IBIO is a developmental stage co. tons of potential, 62M market cap and there is a catalyst tied into $PLX, play for the pop to come
4/5/12
Reply (3)

• !Report Abuse
View all 3 replies
Scott Matusow: my take is basically as I have always said on SPPI; it is a long term investment. Management top notch, typical short term market poop
4/5/12
• !Report Abuse
GaryLee276: Good. I got 1000 more at $10.71.
4/6/12
• !Report Abuse
Add a reply...

140 characters

IBIO iBio, Inc.

IBIO

iBio, Inc.